176 related articles for article (PubMed ID: 32087150)
1. Type 1 Interferon Responses Underlie Tumor-Selective Replication of Oncolytic Measles Virus.
Aref S; Castleton AZ; Bailey K; Burt R; Dey A; Leongamornlert D; Mitchell RJ; Okasha D; Fielding AK
Mol Ther; 2020 Apr; 28(4):1043-1055. PubMed ID: 32087150
[TBL] [Abstract][Full Text] [Related]
2. Mitophagy enhances oncolytic measles virus replication by mitigating DDX58/RIG-I-like receptor signaling.
Xia M; Gonzalez P; Li C; Meng G; Jiang A; Wang H; Gao Q; Debatin KM; Beltinger C; Wei J
J Virol; 2014 May; 88(9):5152-64. PubMed ID: 24574393
[TBL] [Abstract][Full Text] [Related]
3. Sensitivity of human pleural mesothelioma to oncolytic measles virus depends on defects of the type I interferon response.
Achard C; Boisgerault N; Delaunay T; Roulois D; Nedellec S; Royer PJ; Pain M; Combredet C; Mesel-Lemoine M; Cellerin L; Magnan A; Tangy F; Grégoire M; Fonteneau JF
Oncotarget; 2015 Dec; 6(42):44892-904. PubMed ID: 26539644
[TBL] [Abstract][Full Text] [Related]
4. Innate immune defense defines susceptibility of sarcoma cells to measles vaccine virus-based oncolysis.
Berchtold S; Lampe J; Weiland T; Smirnow I; Schleicher S; Handgretinger R; Kopp HG; Reiser J; Stubenrauch F; Mayer N; Malek NP; Bitzer M; Lauer UM
J Virol; 2013 Mar; 87(6):3484-501. PubMed ID: 23302892
[TBL] [Abstract][Full Text] [Related]
5. Tumor and vascular targeting of a novel oncolytic measles virus retargeted against the urokinase receptor.
Jing Y; Tong C; Zhang J; Nakamura T; Iankov I; Russell SJ; Merchan JR
Cancer Res; 2009 Feb; 69(4):1459-68. PubMed ID: 19208845
[TBL] [Abstract][Full Text] [Related]
6. Modulation of the Type I Interferon Response Defines the Sensitivity of Human Melanoma Cells to Oncolytic Measles Virus.
Allagui F; Achard C; Panterne C; Combredet C; Labarrière N; Dréno B; Elgaaied AB; Pouliquen D; Tangy F; Fonteneau JF; Grégoire M; Boisgerault N
Curr Gene Ther; 2017; 16(6):419-428. PubMed ID: 28042780
[TBL] [Abstract][Full Text] [Related]
7. Measles to the Rescue: A Review of Oncolytic Measles Virus.
Aref S; Bailey K; Fielding A
Viruses; 2016 Oct; 8(10):. PubMed ID: 27782084
[TBL] [Abstract][Full Text] [Related]
8. Molecular Effects of Stromal-Selective Targeting by uPAR-Retargeted Oncolytic Virus in Breast Cancer.
Jing Y; Chavez V; Ban Y; Acquavella N; El-Ashry D; Pronin A; Chen X; Merchan JR
Mol Cancer Res; 2017 Oct; 15(10):1410-1420. PubMed ID: 28679779
[TBL] [Abstract][Full Text] [Related]
9. Measles virus activates NF-kappa B and STAT transcription factors and production of IFN-alpha/beta and IL-6 in the human lung epithelial cell line A549.
Helin E; Vainionpää R; Hyypiä T; Julkunen I; Matikainen S
Virology; 2001 Nov; 290(1):1-10. PubMed ID: 11882993
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stem cell carriers protect oncolytic measles viruses from antibody neutralization in an orthotopic ovarian cancer therapy model.
Mader EK; Maeyama Y; Lin Y; Butler GW; Russell HM; Galanis E; Russell SJ; Dietz AB; Peng KW
Clin Cancer Res; 2009 Dec; 15(23):7246-55. PubMed ID: 19934299
[TBL] [Abstract][Full Text] [Related]
11. Dual therapy of ovarian cancer using measles viruses expressing carcinoembryonic antigen and sodium iodide symporter.
Hasegawa K; Pham L; O'Connor MK; Federspiel MJ; Russell SJ; Peng KW
Clin Cancer Res; 2006 Mar; 12(6):1868-75. PubMed ID: 16551872
[TBL] [Abstract][Full Text] [Related]
12. The Role of Neutrophils in Measles Virus-mediated Oncolysis Differs Between B-cell Malignancies and Is Not Always Enhanced by GCSF.
Dey A; Zhang Y; Castleton AZ; Bailey K; Beaton B; Patel B; Fielding AK
Mol Ther; 2016 Feb; 24(1):184-92. PubMed ID: 26278331
[TBL] [Abstract][Full Text] [Related]
13. Transcriptome Analysis of Human Glioblastoma Cells Susceptible to Infection with the Leningrad-16 Vaccine Strain of Measles Virus.
Ammour Y; Susova O; Krasnov G; Nikolaeva E; Varachev V; Schetinina Y; Gavrilova M; Mitrofanov A; Poletaeva A; Bekyashev A; Faizuloev E; Zverev VV; Svitich OA; Nasedkina TV
Viruses; 2022 Nov; 14(11):. PubMed ID: 36366531
[TBL] [Abstract][Full Text] [Related]
14. Interferon-Induced Transmembrane Protein 1 Restricts Replication of Viruses That Enter Cells via the Plasma Membrane.
Smith SE; Busse DC; Binter S; Weston S; Diaz Soria C; Laksono BM; Clare S; Van Nieuwkoop S; Van den Hoogen BG; Clement M; Marsden M; Humphreys IR; Marsh M; de Swart RL; Wash RS; Tregoning JS; Kellam P
J Virol; 2019 Mar; 93(6):. PubMed ID: 30567988
[TBL] [Abstract][Full Text] [Related]
15. Oncolytic measles viruses encoding interferon beta and the thyroidal sodium iodide symporter gene for mesothelioma virotherapy.
Li H; Peng KW; Dingli D; Kratzke RA; Russell SJ
Cancer Gene Ther; 2010 Aug; 17(8):550-8. PubMed ID: 20379224
[TBL] [Abstract][Full Text] [Related]
16. Engineering oncolytic measles virus to circumvent the intracellular innate immune response.
Haralambieva I; Iankov I; Hasegawa K; Harvey M; Russell SJ; Peng KW
Mol Ther; 2007 Mar; 15(3):588-97. PubMed ID: 17245355
[TBL] [Abstract][Full Text] [Related]
17. MAVS-dependent IRF3/7 bypass of interferon β-induction restricts the response to measles infection in CD150Tg mouse bone marrow-derived dendritic cells.
Takaki H; Honda K; Atarashi K; Kobayashi F; Ebihara T; Oshiumi H; Matsumoto M; Shingai M; Seya T
Mol Immunol; 2014 Feb; 57(2):100-10. PubMed ID: 24096085
[TBL] [Abstract][Full Text] [Related]
18. A recombinant measles virus unable to antagonize STAT1 function cannot control inflammation and is attenuated in rhesus monkeys.
Devaux P; Hudacek AW; Hodge G; Reyes-Del Valle J; McChesney MB; Cattaneo R
J Virol; 2011 Jan; 85(1):348-56. PubMed ID: 20980517
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-sensitive oncolytic measles viruses for cancer-specific vector tropism.
Leber MF; Bossow S; Leonard VH; Zaoui K; Grossardt C; Frenzke M; Miest T; Sawall S; Cattaneo R; von Kalle C; Ungerechts G
Mol Ther; 2011 Jun; 19(6):1097-106. PubMed ID: 21468006
[TBL] [Abstract][Full Text] [Related]
20. Mitophagy switches cell death from apoptosis to necrosis in NSCLC cells treated with oncolytic measles virus.
Xia M; Meng G; Jiang A; Chen A; Dahlhaus M; Gonzalez P; Beltinger C; Wei J
Oncotarget; 2014 Jun; 5(11):3907-18. PubMed ID: 25004098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
